Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients.

Trial Profile

Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Levodopa/carbidopa (Primary) ; Antiparkinsonians
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms CECILE
  • Most Recent Events

    • 10 Oct 2016 Status changed from recruiting to completed.
    • 09 Jul 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 14 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top